TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
B/P-Pharma AB
Closing information (x1000 SEK)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
16,327
|
14,799
|
12,678 |
| Financial expenses |
0
|
1
|
0 |
| Earnings before taxes |
163
|
678
|
333 |
| EBITDA |
399
|
896
|
538 |
| Total assets |
5,852
|
6,187
|
5,129 |
| Current assets |
5,068
|
5,496
|
4,315 |
| Current liabilities |
2,092
|
1,998
|
1,466 |
| Equity capital |
3,562
|
3,942
|
3,412 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
4
|
4
|
3 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
60.9%
|
63.7%
|
66.5% |
| Turnover per employee |
4,082
|
3,700
|
4,226 |
| Profit as a percentage of turnover |
1.0%
|
4.6%
|
2.6% |
| Return on assets (ROA) |
2.8%
|
11.0%
|
6.5% |
| Current ratio |
242.3%
|
275.1%
|
294.3% |
| Return on equity (ROE) |
4.6%
|
17.2%
|
9.8% |
| Change turnover |
1,528
|
2,121
|
844 |
| Change turnover % |
10%
|
17%
|
7% |
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % |
0%
|
33%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.